Title : A Randomized Double-Blind Placebo-Controlled Phase IIB Trial of Curcumin in Oral Leukoplakia.

Pub. Date : 2016 Aug

PMID : 27267893






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We investigated the effectiveness of curcumin, a potent inhibitor of NF-kappaB/COX-2, molecules perturbed in oral carcinogenesis, to treat leukoplakia. Curcumin mitochondrially encoded cytochrome c oxidase II Homo sapiens